Matapos umanong mapalakad muli ang isang dagang paralisado, nais ng mga siyentista na subukan na sa tao ang naimbento nilang injectable therapy na tinatawag na "dancing molecules.”
Sa ulat ng Reuters, sinabi ng mga siyentista mula sa Northwestern University, na maaaring natuklasan nila ang gamot para muling makagalaw ang mga paralisado sa pamamagitan ng injectable therapy na matagumpay daw nilang ginawa sa bubuwit.
"Spinal cord injury has been a major challenge for science for decades,” ayon kay Samuel Stupp, ng nangunguna sa isinasagawang pagsasaliksik ng Northwestern University.
“The central nervous system, which includes the brain and the spinal cord, which sends messages between your brain and the rest of your body, has very limited capacity to repair after injury,” paliwanag niya.
Scientists at Northwestern University say they may have found a breakthrough treatment for reversing paralysis in humans after successfully administering a new injectable therapy in mice pic.twitter.com/7cKITjtyu9
— Reuters (@Reuters) November 11, 2021
Sa kanilang pag-aaral, nagawa raw ng “dancing molecules” na i-reverse ang paralysis sa bubuwit at nagamot nito ang severe spinal cord injuries.
Makaraan lang umano ng apat na linggo matapos maturukan ng "dancing molecules" ang bubuwit ay nagawa na nitong makalakad muli.
"This is probably the most important paper I have ever written. And it describes a piece of science that was truly unknown," patuloy ni Stupp.
Ang proseso, ituturok ang likidong "dancing molecules" sa gulugod ng pasyente.
"When molecules did not move or move very little, then the response we observed in the animals was just the slight twitching of the limbs. But no ability to walk. When we use the exact same therapy, the exact same signals, but we molecularly change the structures so that the molecules would move more. Now we saw full ability of the animals to walk," paliwanag niya.
Dagdag pa ni Stupp, "One way to think about this is that if the molecules are dancing around or leaping out of the fibers, the probability that they will meet up with the receptors is increased. We recognize this as a new concept that has never been done and had remarkable success in improving the recovery after spinal cord injury."
Matapos na ilathala sa journal Science ang kanilang pag-aaral, nais ng mga siyentista ng Northwestern team na mabigyan sila ng pahintulot na subukan na ito sa tao, at huwag nang dumaan sa pagsubok sa malalaking hayop.
"We are definitely headed for the FDA to seek approval for use of our novel therapy in clinical trials, and we are very excited about this possibility that will make a huge difference to patients," anang dalubhasa.
Batay sa National Spinal Cord Injury Statistical Center, nasa 300,000 katao sa Amerika ang namumuhay na may spinal cord injury.--FRJ, GMA News
